Is Frontotemporal Dementia Genetic? Essential Guide

Frontotemporal dementia is one of the most misunderstood forms of dementia, partly because it strikes earlier than most people expect. It often begins between ages 45 and 65, and it changes personality and behavior before it ever touches memory. When a family receives this diagnosis, one of the first questions is almost always about inheritance: did we pass this on, and could our children face it too?

The short answer is that genetics plays a real role in frontotemporal dementia, but it is not a simple yes or no. About 10 to 15 percent of all cases run in families in a clear pattern. Another significant portion has some family history without a clear inherited pattern. And many cases appear with no family history at all. Three specific genes account for most of the inherited cases, and researchers continue to find others.

What Is Frontotemporal Dementia?

Frontotemporal dementia, often shortened to FTD, is a group of brain disorders caused by damage to the frontal and temporal lobes of the brain. These are the regions responsible for personality, social behavior, language, and decision-making. When they shrink and lose cells, the effects show up in who a person is and how they act, not primarily in what they remember.

This is a key difference from Alzheimer’s disease. Alzheimer’s most often begins with memory loss. FTD usually begins with changes in behavior, personality, or speech. A person may become apathetic or impulsive. They may say things that are socially inappropriate or lose interest in people they love. In the language variant, they may struggle to find words or understand what others are saying.

FTD is less common than Alzheimer’s disease, but it is a leading cause of dementia in people under 65. Because it starts early, it can affect people in the middle of their careers and while they are still raising children. That timing is part of why the question of genetics feels so urgent to families.

Is Frontotemporal Dementia Genetic?

Genetics contributes to frontotemporal dementia, but it is not the whole story. Three genes are the most well-established causes of inherited FTD. When a person carries a disease-causing change in one of these genes, they have a strong chance of developing FTD, and each of their children has a 50 percent chance of inheriting that same change.

The three main genes are:

• C9orf72 — the most common genetic cause of FTD and also linked to ALS, or Lou Gehrig’s disease
• MAPT — the gene that makes the tau protein, which builds up abnormally in some forms of FTD
• GRN — the gene that makes progranulin, a protein important for brain cell health

Changes in these three genes explain a large share of the cases that clearly run in families. Beyond these, researchers have identified several rarer genes that can also raise risk or cause disease. The list is still growing.

It is important to separate two ideas. Having a genetic cause is different from having a genetic risk factor. A true disease-causing change in C9orf72, MAPT, or GRN strongly predicts the disease. Many other genetic variations only nudge risk up or down and do not guarantee anything.

How Often Does FTD Run in Families?

Roughly 10 to 15 percent of all FTD cases show a clear family pattern, meaning multiple relatives across generations have had FTD, ALS, or a related condition. When researchers look only at people with FTD who also have a strong family history, the share with an identifiable genetic cause rises much higher.

Here is where the numbers need careful handling. Estimates vary because different studies define “family history” differently and study different populations. What is consistent across the research is this: a meaningful minority of cases are clearly inherited, and a large share have no clear family pattern.

That means most people who develop FTD do not have a parent or sibling with it. Having no family history does not rule out a genetic cause, because a gene change can appear for the first time in a person with no affected relatives. But it does make a strong inherited pattern less likely.

What Does It Mean If FTD Runs in Your Family?

A family history matters most when it follows a certain pattern. The clearest signal is FTD, ALS, or a related dementia appearing in multiple close relatives across more than one generation. A single affected relative raises much less concern than a clear line of cases.

When that pattern exists, genetic counseling becomes genuinely useful. A genetic counselor can review the family tree, explain what testing can and cannot tell you, and discuss the emotional weight of knowing. This is not a decision to rush.

Testing is a personal choice with real implications. A positive result for one of the major genes carries a high likelihood of developing the disease, and there is currently no proven way to prevent it. Some people want that knowledge to plan their lives. Others decide they would rather not know. Both are reasonable.

How Is Inherited FTD Passed Down?

Most inherited forms of FTD follow what is called an autosomal dominant pattern. This means a person needs only one copy of the altered gene to be at risk, and each child has a 50 percent chance of inheriting it, regardless of the child’s sex.

If a parent carries the gene change and passes it on, the child has a strong chance of developing FTD at some point. If the child does not inherit the change, they generally cannot pass it to their own children. This 50 percent figure applies to the well-established major genes, not to every genetic variant that has ever been linked to FTD.

One detail that surprises many families: the age when symptoms begin can vary widely, even among relatives who carry the same gene change. Carrying a gene does not tell you exactly when or whether symptoms will start. Researchers are still working to understand what else influences that timing.

Should You Consider Genetic Testing?

Genetic testing for FTD is most appropriate when there is a clear family pattern or when a person has FTD alongside ALS. In those situations, testing can identify the cause and inform relatives about their own risk. Testing a person who already has symptoms is different from testing a healthy relative who has no symptoms.

For healthy people with a family history, testing is a serious decision. There is no treatment that prevents FTD, so a positive result changes your knowledge, not your medical options. Some clinicians recommend waiting until a person is an adult and has thought carefully about the consequences. Guidelines generally advise against testing children for adult-onset conditions like FTD.

No clinical guidelines currently support routine genetic testing for everyone with FTD or for the general public. Testing should be guided by a doctor and a genetic counselor who understand the specific situation.

What About Sporadic FTD With No Family History?

Most FTD cases are not clearly inherited. When no other family members are affected, the cause is often described as sporadic, meaning it appears without a known inherited pattern. In these cases, genetics may still play a small role through common variants that each add a little risk, but no single gene is responsible.

Some of these cases may involve a new gene change that appeared for the first time in the affected person. Others may involve environmental or other factors that researchers do not yet fully understand. This is an active area of study, and much remains unknown.

For families with a single case and no other affected relatives, the risk to children is generally not considered high. A genetic counselor can give a more precise picture based on the specific family history.

What Does the Future Hold for FTD Genetics?

Research into FTD genetics is moving quickly. Scientists have linked the disease to how brain cells handle certain proteins, and this has opened the door to experimental treatments aimed at the underlying biology rather than just the symptoms. Several approaches are in early-stage human trials.

It is important to be honest about where this stands. No treatment has been proven to stop or reverse inherited FTD. Trials are ongoing, and results so far are preliminary. Promising science is not the same as an available treatment.

For families, the most useful step right now is accurate information and access to genetic counseling. Understanding the real role of genetics, without overestimating or dismissing it, helps people make decisions that fit their lives.